人乳腺癌细胞系MCF-7中FOXM1调控SYK转录

doi:10.6040/j.issn.1671-7554.0.2016.187

摘要/Abstract

摘要： 目的探讨人乳腺癌细胞系MCF-7中叉头框转录因子M1(FOXM1)对脾酪氨酸激酶(SYK)表达的调控机制。方法从MCF-7、T47D、SK-BR3和MDA-MB-231中提取RNA和蛋白质,分别用PCR和Western blotting检测SYK的表达水平,并检测SYK基因启动子区CpG岛甲基化。在MCF-7中过表达FOXM1,采用Western blotting和实时荧光定量PCR检测FOXM1和SYK的表达。利用染色质免疫沉淀(ChIP)技术和荧光素酶报告基因检测转录因子FOXM1对SYK基因转录水平的调控作用。结果 SYK在MCF-7中呈阳性表达,而在T47D、SKBR3和MDA-MB-231中呈阴性表达;MCF-7细胞中SYK基因启动子区CpG岛甲基化水平低于对照细胞(P<0.05)。在MCF-7中过表达FOXM1能下调SYK表达,在SK-BR3细胞系中沉默FOXM1基因能激活SYK表达。ChIP结果显示FOXM1直接参与调控SYK的转录;基因沉默FOXM1激活SYK基因启动子活性,过表达FOXM1抑制SYK基因启动子的活性。结论在人乳腺癌细胞系MCF-7中,SYK 是FOXM1的靶基因,FOXM1可能通过调节SYK 的表达来调控乳腺癌的发生发展。

关键词: MCF-7细胞, 叉头框转录因子M1, 转录调控, 乳腺肿瘤, 脾酪氨酸激酶

Abstract: Objective To explore the underlying mechanism of Forkhead box M1(FOXM1)regulating spleen tyrosine kinase(SYK)expression in breast cancer cell line MCF-7. Methods PCR and Western blotting assay were used to analyze the mRNA and protein levels of SYK in MCF-7, T47D, SKBR3 and MDA-MB-231 cells. The methylation status of SYK promoter CpG island was detected. FOXM1 was overexpressed in MCF-7 cells, and then mRNA and protein levels of SYK and FOXM1 were detected. Chromatin immunoprecipitation(ChIP)assay and luciferase reporter assay were adopted to examine whether FOXM1 directly regulated the promoter activity of SYK. Results MCF-7 cells expressed endogenous SYK while T47D, SK-BR3 and MDA-MB-231 cells did not. The rate of DNA methylation of SYK in MCF-7 cells was lower than that in control cells(P<0.05). Overexpression of FOXM1 decreased SYK expression in MCF-7 cells and silence of FOXM1 in SK-BR3 cells increased SYK expression. ChIP assay indicated that FOXM1 directly regulated the transcriptional level of SYK gene. Knockdown of FOXM1 increased the basal SYK promoter activity and overexpression of FOXM1 decreased luciferase activity of SYK in MCF-7 cells. Conclusion SYK is a target gene of FOXM1 in MCF-7, while FOXM1 is involved in the genesis and development of breast cancer by directly regulating SYK.

Key words: MCF-7 cells, Forkhead box protein M1, Transcriptional regulation, Breast cancer, Spleen tyrosine kinase

中图分类号:

孟繁超,冯鹭,邵广瑞. 人乳腺癌细胞系MCF-7中FOXM1调控SYK转录[J]. 山东大学学报（医学版）, 2017, 55(3): 19-24.

MENG Fanchao, FENG Lu, SHAO Guangrui. FOXM1 regulates transcription of SYK in breast cancer cell line MCF-7[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(3): 19-24.

参考文献

[1] Siegel RL, Fedewa SA, Miller KD, et al. Cancer statistics for Hispanics/Latinos, 2015[J]. CA Cancer J Clin, 2015, 65(6): 457-480.
[2] Pfister NT, Fomin V, Regunath K, et al. Mutant p53 cooperates with the SWI/SNF chromatin remodeling complex to regulate VEGFR2 in breast cancer cells[J]. Genes Dev, 2015, 29(12): 1298-1315.
[3] Wang N, Ding H, Liu C, et al. A novel recurrent CHEK2 Y390C mutation identified in high-risk Chinese breast cancer patients impairs its activity and is associated with increased breast cancer risk[J]. Oncogene, 2015, 34(40): 5198-5205.
[4] Sung YM, Xu X, Sun J, et al. Tumor suppressor function of SYK in human MCF10A in vitro and normal mouse mammary epithelium in vivo[J]. PLoS One, 2009, 4(10): e7445. doi:10.1371 /journal.pone.0007445.
[5] Zhang X, Shrikhande U, Alicie BM, et al. Role of the protein tyrosine kinase SYK in regulating cell-cell adhesion and motility in breast cancer cells[J]. Mol Cancer Res, 2009, 7(5): 634-644.
[6] Yuan Y, Mendez R, Sahin A, et al. Hypermethylation leads to silencing of the SYK gene in human breast cancer[J]. Cancer Res, 2001, 61(14): 5558-5561.
[7] 盖领, 茅国新, 赵铃铃, 等. FOXM1在人乳腺癌组织和MCF-7细胞中的表达及临床意义[J]. 基础医学与临床, 2015, 35(8): 1100-1105. GAI Ling, MAO Guoxin, ZHAO Lingling, et al. Expression and clinical significance of FOXM1 in breast cancer tissues and MCF-7 cells[J]. Basic & Clinical Medicine, 2015, 35(8): 1100-1105.
[8] Katz E, Dubois-Marshall S, Sims AH, et al. A gene on the HER2 amplicon, C35, is an oncogene in breast cancer whose actions are prevented by inhibition of SYK[J]. Br J Cancer, 2010, 103(3): 401-410.
[9] Abram, CL, Lowell CA, The expanding role for ITAM-based signaling pathways in immune cells[J]. Sci STKE, 2007, 2007(377): re2. doi: 10.1126 /stke.3772007re2.
[10] Geahlen RL.SYK and pTyrd: Signaling through the B cell antigen receptor[J]. Biochim Biophys Acta, 2009, 1793(7): 1115-1127.
[11] Hong J, Yuan Y, Wang J, et al. Expression of variant isoforms of the tyrosine kinase SYK determines the prognosis of hepatocellular carcinoma[J]. Cancer Res, 2014, 74(6): 1845-1856.
[12] 田甜甜, 李际盛, 王亚伟, 等. 染料木黄酮在小细胞肺癌H446细胞中通过抑制FoxM1通路发挥抗肿瘤作用[J]. 山东大学学报(医学版), 2013, 51(6): 44-48. TIAN tiantian, LI jisheng, WANG Yawei, et al. Genistein exerts anti-tumor effects in small cell lung cancer H446 cells via suppressing the activity of FoxM1 pathway[J]. Journal of Shandong University(Health Science), 2013, 51(6): 44-48.
[13] 张红雨, 费立明, 王长亮, 等. 胰腺癌SYK表达与病理分期及血管生成的相关性[J]. 山东大学学报(医学版), 2008, 46(9): 880-883. ZHANG Hongyu, FEI Liming, WANG Changliang, et al. Correlations of SYK with pathology and angiogenesis of pancreatic adenocarcinoma[J]. Journal of Shandong University(Health Science), 2008, 46(9): 880-883.
[14] Wang S, Ding YB, Chen GY, et al. Hypermethylation of SYK gene in promoter region associated with oncogenesis and metastasis of gastric carcinoma[J]. World J Gastroenterol, 2004, 10(12): 1815-1818.
[15] Krisenko MO, Geahlen RL. Calling in SYK: SYKs dual role as a tumor promoter and tumor suppressor in cancer[J]. Biochim Biophys Acta, 2015, 1853(1): 254-263.
[16] Shin SH, Lee KH, Kim BH, et al. Downregulation of spleen tyrosine kinase in hepatocellular carcinoma by promoter CpG island hypermethylation and its potential role in carcinogenesis[J]. Lab Invest, 2014, 94(12): 1396-1405.
[17] Teh MT, Gemenetzidis E, Patel D, et al. FOXM1 induces a global methylation signature that mimics the cancer epigenome in head and neck squamous cell carcinoma[J]. PLoS One, 2012, 7(3): e34329. doi: 10.1371/journal.pone.0034329. Epub 2012 Mar 26.
[18] Li J, Sidell N. Growth-related oncogene produced in human breast cancer cells and regulated by Syk protein-tyrosine kinase[J]. Int J Cancer, 2005, 117(1): 14-20.
[19] Yu M, Tang Z, Meng F, et al. Elevated expression of FOXM1 promotes the tumor cell proliferation in hepatocellular carcinoma[J]. Tumour Biol, 2016, 37(1):1289-1297.
[20] Baranski OA, Kalinichenko VV, Adami GR. Increased FOXM1 expression can stimulate DNA repair in normal hepatocytes in vivo but also increases nuclear foci associated with senescence[J]. Cell Prolif, 2015, 48(1): 105-115.
[21] Song IS, Jeong YJ, Jeong SH, et al. FOXM1-induced PRX3 regulates stemness and survival of colon cancer cells via maintenance of mitochondrial function[J]. Gastroenterology, 2015, 149(4): 1006-1016.
[22] Ning Z, Wang A, Liang J, et al. USP22 promotes the G1/S phase transition by upregulating FOXM1 expression via beta-catenin nuclear localization and is associated with poor prognosis in stage II pancreatic ductal adenocarcinoma[J]. Int J Oncol, 2014, 45(4): 1594-1608.
[23] Wonsey DR, Follettie MT. Loss of the forkhead transcription factor FOXM1 causes centrosome amplification and mitotic catastrophe[J]. Cancer Res, 2005, 65(12): 5181-5189.
[24] Ahmad A, Wang Z, Kong D, et al. FOXM1 down-regulation leads to inhibition of proliferation, migration and invasion of breast cancer cells through the modulation of extra-cellular matrix degrading factors[J]. Breast Cancer Res Treat, 2010, 122(2): 337-346.

相关文章 15

[1]	田斯琦,刘日强,杨宁,韦薇,杨华伟. 核糖体S6蛋白激酶4变异体基因表达对乳腺癌细胞增殖的影响[J]. 山东大学学报（医学版）, 2016, 54(9): 32-36.
[2]	李冉冉,张鹏飞,袁冰,房菲菲, 韩明勇. 乳腺癌MCF-7细胞分泌的血管内皮生长因子诱导血管内皮细胞免疫功能抑制[J]. 山东大学学报（医学版）, 2016, 54(2): 38-43.
[3]	高永生, 王春健, 蔡淑萍, 孙菊杰, 张德贤, 孙妍琳, 穆殿斌. Netrin-1在乳腺浸润性导管癌中的表达及与转移的相关性[J]. 山东大学学报（医学版）, 2015, 53(7): 39-42.
[4]	孙莹, 于晶, 魏军民, 樊聪, 王秀问, 高鹏, 江立玉, 马婷婷. 35岁以下女性乳腺癌患者的临床病理特征[J]. 山东大学学报（医学版）, 2014, 52(7): 71-74.
[5]	张洪梅1,2，王宏2，陈洪丽2，李迎新2，徐应军1，关维俊1，顾立超3,陈乃耀3. PSD-007对人乳腺癌MCF-7细胞的光动力杀伤效应[J]. 山东大学学报（医学版）, 2014, 52(2): 52-57.
[6]	白杨1，崔国忠1，戴殿禄1，桑梅香2，耿翠芝3. Bax基因多态性与乳腺癌临床病理特点的关系[J]. 山东大学学报（医学版）, 2014, 52(1): 71-74.
[7]	石焕1,2，邵倩倩1，孙锦堂1，宋丙凤1，吕静1,3，何影1，张韵1，曲迅1. 罗勒多糖对乳腺癌细胞系MDA-MB-231侵袭的影响[J]. 山东大学学报(医学版), 2013, 51(9): 50-54.
[8]	迟蔚蔚1，高海燕2，高海东3. 转化生长因子β1诱导的跨膜蛋白参与乳腺癌发展的分子机制[J]. 山东大学学报(医学版), 2013, 51(4): 26-29.
[9]	李珊珊，孙颖，丁涣，黎莉. β-catenin在不同亚型乳腺癌中的表达及其临床意义[J]. 山东大学学报(医学版), 2013, 51(3): 107-110.
[10]	岑东芝. NRIP3基因高表达抑制淋巴结阴性乳腺癌转移的研究[J]. 山东大学学报(医学版), 2012, 50(9): 83-.
[11]	王婧男1，郑燕2，肖东杰2，李金星1，丁卜同2，刘相东3，汪运山2，4. SATB1与HER2表达和乳腺癌分化程度的相关性[J]. 山东大学学报(医学版), 2012, 50(9): 91-.
[12]	张家鑫，马忠兵，于理想，刘丽媛，王斐，郭明明，王峰，余之刚. 血清脂联素、瘦素水平与乳腺癌相关性的初步研究[J]. 山东大学学报(医学版), 2012, 50(6): 110-.
[13]	庄婷1，薛梅2，房爱菊3，管冰心1，梁艳1，王志蕙2，王妍1，孟斌1. 黏蛋白(MUC1、MUC2、MUC5AC和MUC6)在乳腺浸润性导管癌中的表达及意义[J]. 山东大学学报(医学版), 2012, 50(5): 107-111.
[14]	万越，陈守华，顾禾，张丽丽. 硼替佐米联合表阿霉素对乳腺癌细胞增殖与凋亡的影响[J]. 山东大学学报(医学版), 2012, 50(2): 43-46.
[15]	杨欢，梁婷，张超，宋静，郝静，侯桂华 . 131I- rFliC的制备及乳腺癌荷瘤鼠体内生物学分布特征[J]. 山东大学学报(医学版), 2012, 50(12): 31-36.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed